Sympathetic activation in obese normotensive subjects

Area of Science:

• Cardiovascular Physiology
• Obesity Research
• Autonomic Nervous System Function

Background:

• Human obesity presents complex hemodynamic and metabolic changes.
• The role of sympathetic nervous system (SNS) activation in obesity remains debated.
• Understanding SNS involvement is crucial for managing obesity-related cardiovascular risks.

Purpose of the Study:

• To investigate sympathetic nervous system activity in young, normotensive obese individuals compared to lean controls.
• To determine if obesity is associated with heightened sympathetic drive, independent of blood pressure alterations.

Main Methods:

• Measured beat-to-beat arterial blood pressure, heart rate, and muscle sympathetic nerve activity (MSNA) via microneurography.
• Assessed venous plasma norepinephrine levels.
• Evaluated baroreceptor reflex sensitivity using phenylephrine and nitroprusside infusions.

Main Results:

• Obese subjects showed significantly higher baseline MSNA (38.6 +/- 5.1 bursts/min) than lean controls (18.7 +/- 1.3 bursts/min).
• Plasma norepinephrine levels were similar between groups.
• Baroreceptor reflex responses (heart rate and MSNA changes) to blood pressure manipulation were attenuated in obese individuals.

Conclusions:

• Human obesity is characterized by marked sympathetic activation, even in the absence of hypertension.
• Impaired reflex sympathetic restraint may underlie this heightened sympathetic drive in obesity.
• This sympathetic overactivity could contribute to the increased incidence of hypertension and cardiovascular complications in obese individuals.